Who owns the RESILIA PHARMACEUTICALS trademark?

The RESILIA PHARMACEUTICALS trademark is owned by Peak Pharma Commercial Partners, LLC.

What class is the RESILIA PHARMACEUTICALS trademark registered in?

The RESILIA PHARMACEUTICALS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for RESILIA PHARMACEUTICALS?

The USPTO serial number for RESILIA PHARMACEUTICALS is 90448104.

What is the registration number for RESILIA PHARMACEUTICALS?

RESILIA PHARMACEUTICALS is registered under USPTO registration number 7202460.

RES

USPTO Trademark Record

REGISTERED

RESILIA PHARMACEUTICALS

SN 90448104·Reg 7202460·Filed Jan 05, 2021

Owner Peak Pharma Commercial Partners, LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

RESILIA PHARMACEUTICALS (Serial No. 90448104), Registration No. 7202460, is a registered US trademark filed on Jan 05, 2021 by Peak Pharma Commercial Partners, LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: October 24, 2029

Mark Intelligence

RESILIA PHARMACEUTICALS (Reg. #7202460) is a registered US trademark that has been protecting its owner, Peak Pharma Commercial Partners, LLC, since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 05, 2021

SERIAL

90448104

REG#

7202460

REGISTERED

Oct 24, 2023

Owner

Applicant

Peak Pharma Commercial Partners, LLC

Entity

LLC

State

Address

301 East 45th Street, Suite 18-F, New York, NY, 10017

Country

Attorney

NameJulie Beth Albert

Law firm

Julie Beth Albert BAKER BOTTS L.L.P.

Docket

084365.0108

Address

30 ROCKEFELLER PLAZA, 44TH FLOOR, NEW YORK, NY 10112-4498, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJan 05, 2021

Serial Number90448104

Registration No.7202460

Registration DateOct 24, 2023

Status DateOct 24, 2023

Published for OppositionDec 07, 2021

Mark TypeStandard characters

Attorney Docket084365.0108

Status DescriptionLive and registered

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: May 03, 2023

First use in commerce: May 03, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

37 events

REGISTERED-PRINCIPAL REGISTER

Oct 24, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 24, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 19, 2023

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 16, 2023

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 14, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 14, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 14, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

SU - NON-FINAL ACTION - WRITTEN

Jun 22, 2023

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Jun 22, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 22, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Jun 01, 2023

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 30, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 30, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

May 08, 2023

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

May 08, 2023

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 31, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jan 27, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Jan 27, 2023

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Jan 27, 2023

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 13, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jul 11, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Jul 11, 2022

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Jul 11, 2022

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 01, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Dec 07, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 07, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 17, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 03, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 02, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 02, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 02, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Jul 22, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jul 22, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 22, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jul 14, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 03, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jan 08, 2021

NEW APPLICATION ENTERED

RESILIA PHARMACEUTICALS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Peak Pharma Commercial Partners, LLC

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Julie Beth Albert

Resources

Company